Gsk Share Discussion Threads

[montyhedge] 14/9/2017 19:44

Ny BoyNever given a tick up or down ever on Advfn. Can't see the point.

[romeike] 14/9/2017 15:41

Yes supposedly all these dirty banks are now a fantastic buy because interest rates might go up 0.25 sometime in the next two years

[essentialinvestor] 14/9/2017 15:40

May be an opportunity tomorrow.

[philanderer] 14/9/2017 13:40

14th sept HSBC buy tp 2000p up from 1970p

[romeike] 14/9/2017 11:43

To be clear, final approval should be soon, technically FDA can ignore its own biologics advisory team's recommendation but I can't remember that ever happening. And just to reiterate, the recommendation was unanimous.

[ny boy] 14/9/2017 10:10

No the actual FDA approval should follow in a few weeks, I'm in no rush but took the opportunity to top up yesterday.

Something nice to look forward to here, apart from the divi!

[tompion] 14/9/2017 10:07

I think the market was expecting approval - thus no response.

[ny boy] 14/9/2017 09:48

Don't worry about Monty, he is quite harmless &usually misses the move, his main claim to fame is giving me a red thumbs down for each of my posts.. watch this one receive one soon lol!

[spcecks] 14/9/2017 09:46

Good news.

[jadeticl3] 14/9/2017 09:29

Maybe the Market is full of Montys!!!

[philanderer] 14/9/2017 09:24

Market well impressed ;-)

[romeike] 14/9/2017 09:21

Who is this Monty idiot? The GSK vaccine just recommended for approval by FDA within days is a potentially billion dollar per annum vaccine that is far more advanced and effective than the old Merck option.

I am afraid you just wasted your £160 because the advice is to revaccinate all patients with the new GSK vaccine because it is so much more effective. A pity you don't take any interest in the science or the products around the companies you short.

[tompion] 14/9/2017 09:06

GSK vaccine is better Monty ...

[tradermichael] 14/9/2017 09:02

Here's the actual DJ release:

LONDON-GlaxoSmithKline PLC's (GSK.LN) shingles vaccine Shingrix, or HZ/su, has been approved for adults aged 50 and over by the U.S. Food and Drug Administration's Advisory Committee.

The pharmaceutical company said Thursday that the FDA's vaccines and related biological products advisory committee, or VRBPAC, voted unanimously that the data support the efficacy and safety of Shingrix for the prevention of herpes zoster or shingles.

The FDA Advisory Committees provide nonbinding recommendations for consideration by the FDA, with the final decision on approval made by the FDA, GSK said.

"Thursday's vote brings us one step closer to approval of Shingrix, which is specifically designed to overcome age-related weakening of the immune system," said Dr. Emmanuel Hanon, senior vice president and head of vaccines research and development.

GSK's shingles candidate vaccine is not currently approved for use anywhere in the world. Regulatory filings in the European Union, Canada, Australia and Japan are underway

[montyhedge] 14/9/2017 09:00

There is a vaccine already, had it last week cost me £160.

[tompion] 13/9/2017 15:42

You can follow FDA deliberations on twitter @shingrix.

[ny boy] 13/9/2017 11:38

Bought more @ 1480p, looks like a classic bear trap before positive news

[romeike] 13/9/2017 11:13

I haven't seen any good reason to preclude approval, the clinical trial results and safety have been absolutely excellent and the efficacy and economics even justify re-vaccination of people previously supplied the Merck vaccine. This is a big deal, failure here would be especially bad given Emma's more focused strategy. Approval helps prove the "finger in the air" analysts wrong and should set us back on the track to £18+.

Current reprieve for Advair revenues being completely ignored in latest analyst reports with over hyped "concern" over competition in HIV space where GSK is currently the pace setter.

[tradermichael] 13/9/2017 10:11

Potential is >$700 million pa sales

[spcecks] 13/9/2017 09:47

Hope it goes in our favour.

[romeike] 13/9/2017 09:18

The ftse is generally down and healthcare is generally down even more

I am sure we are due a decision from FDA on Shingrix today - this is a critical approval for what is likely a blockbuster vaccine that is a huge improvement on the current option

[zho] 13/9/2017 09:12

>>Cannot understand the drop>>

Dollar weakness? $1.33 against $1.30 a few days ago.

[philanderer] 13/9/2017 09:10

13th sept JP Morgan Caz neutral tp 1570p cut from 1750p